Share from 0:00
0:00
/

Are We Listening to Patients Early Enough to Make a Difference?

Wenora Johnson went from a stage 3B colorectal cancer diagnosis to helping shape clinical trials, and she has one question every healthcare organization should be able to answer.

Wenora Johnson said one sentence twice on purpose. “Are we listening to patients early enough for their input to actually make a difference?”

She wanted us to hear it, so I’ll say it again here. Hold onto that question, because the rest of our conversation builds toward it.

Wenora has spent more than 20 years supporting CEOs, professors, and customers across hospitality, education, and aviation. Then cancer changed the direction of her work. She’s now a patient and research advocate, and she shared how she got from there to here.

She wasn’t thinking about advocacy. She was thinking about surviving.

Wenora was diagnosed with stage 3B colorectal cancer in 2011, at 44. She told me she wasn’t thinking about becoming an advocate at that point. She was thinking about getting through it.

I always tell people it took me three days to realize I needed to do something with my diagnosis. Wenora’s moment came differently. The words “you have cancer” were a flyby at first, she said. It sank in when she sat in the infusion chair for the first time, hooked up for four-plus hours, and thought, “Okay, this is how this is going to work.”

There’s no right timeline for that moment. Some people find a purpose in days. Some never go looking for one, and that’s okay too. Nobody owes the world their story.

A doctor who connected the dots

Years later, Wenora’s oncologist did something that doesn’t happen often enough. Wenora mentioned her family history, and her doctor put it together and suggested she might have Lynch syndrome, a hereditary condition. She encouraged genetic testing at nearly every visit, gently, until Wenora said yes.

The test confirmed it in 2016. Wenora says it led to an early-stage endometrial cancer being found, and she credits that test with saving her life. It also reshaped her advocacy around genetics, family history, and prevention. Lynch syndrome means her children have a 50 percent chance of carrying it too, and she’s honest that she can’t make them act. They’re adults. She’s learned the message may need to come from someone other than Mom, and she’ll be there when it does.

I told her what I’ll say again here. Clinicians who look out for what we don’t know to ask about are rare, and they deserve credit.

A seat at the table is the starting line

Wenora’s work began with awareness. She shared her story and encouraged screening. Today she’s involved in clinical trial design, research reviews, patient-reported outcomes, health literacy, policy discussions, and organizational governance.

She also said something I wish more people believed. Patient advocates don’t have to become scientists to contribute to science. Lived experience is its own kind of expertise.

Her definition of advocacy is about what happens after you’re invited. Here are the questions she says advocacy asks:

  • Does this clinical trial reflect what matters to patients?

  • Can patients actually understand the consent forms?

  • Are we counting the financial burden of taking part?

  • Are we including people who have been left out of research before?

“We shouldn’t measure meaningful patient engagement simply by how many patients participated,” she said. We should ask what changed because they were involved. I told her that was going to be a clip, and I meant it.

How do you know it’s making a difference?

I asked how she knows her work matters, since passion alone doesn’t pay the bills or fill the calendar. Her answer surprised me. This year she started keeping track, and she gathered her stories and blog posts into a 95-page book called Unbreakable. She hadn’t realized how much she’d written until it was in one place.

She also reminded me that advocates need reminders too. Late-night calls from someone newly diagnosed, with no idea who to trust, are part of the job, and her answer is always yes. For me, the only impact I need is helping one person. Wenora feels the same.

What I hope organizations hear

If Wenora had a magic wand, she’d make meaningful patient engagement the expectation across healthcare and research. Not after decisions are made. Not only when a study needs participants or an organization needs a story. From the beginning, when research questions are written, trials are designed, policies are drafted, and outcomes are judged. She wants that involvement to be accessible, equitable, appropriately compensated, and measurable.

If you work in a professional association, health system, pharmaceutical, diagnostic, or biotech company, here are a few questions worth taking back to your team:

  • At what stage do patients first see your project? Before the questions are written, or after?

  • Are patient partners paid for their expertise?

  • Could you show what changed because patients were involved?

  • Who isn’t in the room yet?

Wenora said it simply: if we say patients are partners, we need to treat them as partners.

If you’re a patient or caregiver

You don’t have to become an advocate. But if you’ve ever wondered whether your experience counts, it does. Share it, or don’t. If you do, ask what it could be used for. A text to someone newly diagnosed, a question at a meeting, a conversation about family history over dinner: that’s advocacy too.

A few things you won’t get from the headlines

Wenora served eight years as a Navy reservist, mostly with a unit in Italy, and it gave her the courage to ride a motorcycle. Her favorite bike is a Yamaha V-Star. Prince is a favorite for the way his music reminds her not to sit back and feel sorry for herself. When I asked about her favorite color, she told me her four-year-old granddaughter had answered “all of the colors” that very morning, and she borrowed the answer.

Connect with Wenora on LinkedIn. She promises she’ll answer your message.
And be sure to follow her to learn when her book, Unbreakable, is available!

One more thing

If this conversation was useful to you, subscribe so you don’t miss an episode. New conversations land every Thursday.

And I’d love your help with something. Who should I talk to next? A patient, caregiver, advocate, researcher, or someone inside an organization doing patient engagement well? Reply or leave a comment with your suggestions.

Discussion about this video

User's avatar

Ready for more?